Interview: Fueling Innovation with a Client-Centric Approach

The best-fit solution for your endeavor - Rentschler Development Services At Rentschler Biopharma, we are committed to being your strategic partner, providing not just solutions but also expert support that empowers your success and contribution to the treatment of serious and rare diseases. We recognize the importance of providing our clients with the best-fit solution to realizing their ideas and projects. Our Rentschler Development Services Program is a comprehensive framework aimed at tailoring development projects to clients’ particular needs and project stages. Our goal is to empower our clients by offering a range of tailored services. Whether you’re a startup or an established player, we understand that one size does not fit all. With the Development Services Program, you can choose from three different options: Velocity, Flexibility, and Liberty. Click to discover more Velocity Velocity is our fast-track service offering for clients who must be fast. With our fixed timelines, fixed prices and standardized processes , we reliably deliver released Drug Substance for your clinical Phase I/II project on-time. Click to discover more Flexibility Sometimes our clients require flexibility due to shifting priorities, unforeseen challenges, or changing market dynamics. Flexibility provides you with customized timelines and ensures that you can pivot, when necessary, without compromising quality independent of the clinical phase . Click to discover more Liberty For our clients who thrive on experimentation and innovation, Liberty offers you standalone activities and work packages to test hypotheses, fill a specific gap in your portfolio, iterate rapidly, and stay ahead of the wave . Click to discover more Interested? Then get in touch with our Business Development team at BIO International Convention or contact us via our website . | At Rentschler Biopharma we are setting new standards in biologics development and manufacturing through our client-first approach. By making significant investments in our US and German sites and launching our Rentschler Development Services, we are well-positioned to offer flexible and tailored solutions to its clients. In this interview, Christiane Bardroff, our Chief Operating Officer, and Patrick Meyer, our Global Head of Business Development , emphasize how this strategy not only fuels innovation but also furthers the capabilities at Rentschler’s state-of-the-art facility in Milford, MA. Watch this video to learn more about: What role the digital transformation, AI and automation play in biologics How we work as our clients’ partners to drive innovation in biologics development and manufacturing. What client centricity means to us at Rentschler Biopharma